Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fusion Pharmaceuticals Inc (NQ: FUSN )

9.510 -0.610 (-6.03%)
Official Closing Price Updated: 5:08 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,100
Open 10.06
Bid (Size) 9.500 (1)
Ask (Size) 11.49 (2)
Prev. Close 10.12
Today's Range 9.500 - 10.08
52wk Range 9.310 - 19.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Fusion Pharmaceuticals Announces Preclinical Combination Data Demonstrating Enhanced Efficacy in Multiple Preclinical Tumor Models
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the presentation of... 
From PR Newswire
Fusion Pharmaceuticals Announces Closing of Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it has completed the... 
From PR Newswire

Performance

YTD
-18.23%
-18.23%
1 Month
-15.39%
-15.39%
3 Month
-18.09%
-18.09%
6 Month
-22.11%
-22.11%
1 Year
-44.06%
-44.06%

More News

Read More
Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
From PR Newswire
Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results and Business Update
From PR Newswire
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
From PR Newswire
Fusion Pharmaceuticals To Present At The Cowen 41st Annual Health Care Conference
From PR Newswire
Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to Board of Directors
From PR Newswire
Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly
Tags Emerging Markets VKTX ATNM
From Benzinga
Oversold Conditions For Fusion Pharmaceuticals
Tags Stocks
From Market News Video
Stocks That Hit 52-Week Lows On Monday
Tags TEO NEW Movers
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Tags DNB 52 Week Lows Trading Ideas
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]